BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24681959)

  • 21. SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells.
    Seo HS; Ku JM; Lee HJ; Woo JK; Cheon C; Kim M; Jang BH; Shin YC; Ko SG
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28864784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death.
    Makhov P; Golovine K; Teper E; Kutikov A; Mehrazin R; Corcoran A; Tulin A; Uzzo RG; Kolenko VM
    Br J Cancer; 2014 Feb; 110(4):899-907. PubMed ID: 24434432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
    Chen H; Guan Y; Yuan G; Zhang Q; Jing N
    Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J; Li RJ; Cheng MS; Kim YS
    Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Wang F; Mao Y; You Q; Hua D; Cai D
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma.
    Golovine K; Makhov P; Naito S; Raiyani H; Tomaszewski J; Mehrazin R; Tulin A; Kutikov A; Uzzo RG; Kolenko VM
    Cancer Biol Ther; 2015; 16(5):743-9. PubMed ID: 25801713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.
    Rajendran P; Li F; Manu KA; Shanmugam MK; Loo SY; Kumar AP; Sethi G
    Br J Pharmacol; 2011 May; 163(2):283-98. PubMed ID: 21198544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acacetin Inhibits the Growth of STAT3-Activated DU145 Prostate Cancer Cells by Directly Binding to Signal Transducer and Activator of Transcription 3 (STAT3).
    Yun S; Lee YJ; Choi J; Kim ND; Han DC; Kwon BM
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piperlongumine loaded PLGA nanoparticles inhibit cancer stem-like cells through modulation of STAT3 in mammosphere model of triple negative breast cancer.
    Singh P; Sahoo SK
    Int J Pharm; 2022 Mar; 616():121526. PubMed ID: 35104598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo.
    Duan C; Zhang B; Deng C; Cao Y; Zhou F; Wu L; Chen M; Shen S; Xu G; Zhang S; Duan G; Yan H; Zou X
    Tumour Biol; 2016 Aug; 37(8):10793-804. PubMed ID: 26874726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
    Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
    Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
    Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
    Wang J; Xu J; Xing G
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in HER2-overexpressing BT-474 breast cancer cells.
    Seo HS; Ku JM; Choi HS; Choi YK; Woo JK; Kim M; Kim I; Na CH; Hur H; Jang BH; Shin YC; Ko SG
    Oncol Rep; 2016 Jul; 36(1):31-42. PubMed ID: 27175602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
    PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.
    Li F; Rajendran P; Sethi G
    Br J Pharmacol; 2010 Oct; 161(3):541-54. PubMed ID: 20880395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M; Li C; Lin J; Javle M
    Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.